Waranya Rattanavipapong joined the Health Intervention and Technology Assessment Program (HITAP) in February 2010. She graduated with a Bachelor’s Degree in Pharmacy from from Srinakharinwirot University in 2008, majoring in Social and Administrative Pharmacy & Clinical Pharmacy. In 2013, she was awarded the Capacity Building of Researchers in Health Policy and System Research Scholarship by the International Health Policy Program Foundation to pursue a Master’s degree in Health Economics and Decision Modelling from the University of Sheffield and graduated in 2014. She is interested in conducting economic evaluations of health interventions and programs and pharmacoeconomic research. During the past five years, she has been involved in several research projects to support national and international policy making. Previous research includes the cost-utility analysis of 7-, 10- and 13-valent Pneumococcal conjugate vaccine in Thailand, the economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand, and an economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan.